Galmed Pharmaceuticals Stock Forecast

Sell candidate since Jun 22, 2026

The Galmed Pharmaceuticals Ltd. stock price fell by -2.74% on the last day (Monday, 22nd Jun 2026) from $0.580 to $0.564. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 15.90% from a day low at $0.526 to a day high of $0.610. The price has fallen in 6 of the last 10 days and is down by -18.95% for this period. Volume has increased on the last day by 707 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 749 thousand shares were bought and sold for approximately $422.35 thousand.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Galmed Pharmaceuticals Ltd. stock with a 90% probability to be traded between $0.473 and $0.794 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

GLMD Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 20.20%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Galmed Pharmaceuticals Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.599 and $0.613. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Galmed Pharmaceuticals Ltd. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Galmed Pharmaceuticals Ltd. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.525 and $0.522. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Galmed Pharmaceuticals Ltd. finds support just below today's level at $0.525. If this is broken, then the next support from accumulated volume will be at $0.522 and $0.469.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0837 between high and low, or 15.90%. For the last week, the stock has had daily average volatility of 9.18%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GLMD) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Galmed Pharmaceuticals Ltd. to open at $0.567, and during the day (based on 14 day Average True Range), to move between $0.526 and $0.602, which gives a possible trading interval of +/-$0.0761 (+/-14.48%) up or down from last closing price. If Galmed Pharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 14.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.525 (6.93%) than the resistance at $0.616 (9.18%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Galmed Pharmaceuticals Ltd. stock A Buy?

Galmed Pharmaceuticals Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.150 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $0.567 ( 0.479%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk